Vimarsana
Biggest News Aggregation in the World

Page 10 - Technical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technical Studies Today - Breaking & Trending Today

SIFC identifies 9 power projects worth $6.87bn - Business Recorder - Vimarsana News

SIFC identifies 9 power projects worth $6.87bn - Business Recorder

ISLAMABAD: The Special Investment Facilitation Council (SIFC) has identified nine power sector projects at an...

First Mining Announces Positive Preliminary Economic Assessment for the Duparquet Gold Project, Quebec, Canada - Vimarsana News

First Mining Announces Positive Preliminary Economic Assessment for the Duparquet Gold Project, Quebec, Canada

Pre-Tax NPV5% of C$1.07 billion, After-Tax NPV5% of C$588 millionPre-Tax IRR of 24.9%, After-Tax IRR of 18.0%Average LOM Annual Gold Production of 233 koz with AISC of US$976/oz over 11-year...

First Mining Gold Announces Positive Preliminary Economic Assessment for the Duparquet Gold Project, Quebec, Canada - Vimarsana News

First Mining Gold Announces Positive Preliminary Economic Assessment for the Duparquet Gold Project, Quebec, Canada

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM - Vimarsana News

Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM

MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Vienna from 9 - 13 September 2023. Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118) will be presented in on oral session on Sunday 10 September. In addition, the co...

A birthday gift from Zippy - Vimarsana News

A birthday gift from Zippy

With 35 years of post-secondary schooling under his belt, Greathouse received his hard earned Associate Degree of Technical Studies on Aug. 14, 2023. He was surrounded by immediate family and his new collegiate family in the College of Arts and Sciences Building Atrium.